Interferon-β induction by Chlamydia pneumoniae in human smooth muscle cells

FEMS Immunology and Medical Microbiology

Volumn 32, Issue 1, 2001, Pages 9-15

  Rödel, Jürgen ^a   Assefa, Sentayehu ^a   Prochnau, Dirk ^a   Woytas, Marcus ^a   Hartmann, Matthias ^a   Groh, Annemarie ^a   Straube, Eberhard ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Chlamydia pneumoniae; Interferon regulatory factor; Interferon ; Smooth muscle cell

Indexed keywords

BETA INTERFERON; CELL PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 9; MESSENGER RNA; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BRONCHUS MUSCLE; CELL LEVEL; CELL STIMULATION; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TISSUE REGENERATION; VASCULAR SMOOTH MUSCLE;

BRONCHI; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON-BETA; INTERFERON-STIMULATED GENE FACTOR 3; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; PHOSPHOPROTEINS; TRANSCRIPTION FACTORS;

EID: 0035662811     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(01)00274-7     Document Type: Article

References (43)

1. Intracellular pathogens and their role in asthma: Chlamydia pneumoniae in adult patients
2. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infection
3. Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma?
4. Asthma, atopy and Chlamydia pneumoniae antibodies in adults
5. Airway remodelling in asthma
6. Chlamydia pneumoniae and vascular disease
7. Chlamydia pneumoniae induces inflammatory changes in the aortas of rabbits
8. De novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model
9. Chlamydia pneumoniae and atherosclerosis: Does the evidence support a causal or contributory role?
10. Growth factors and arterial smooth muscle proliferation
11. Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery
12. Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae
13. Airway smooth muscle cell culture: Application to studies of airway remodelling and phenotype plasticity
14. Basic fibroblast growth factor in asthma: Measurement in bronchoalveolar lavage fluid basally and following allergen challenge
15. Interferon-β: A potential autocrine regulator of human vascular smooth muscle cell growth
16. Reversion of the antichlamydial effect of tumor necrosis factor by tryptophan and antibodies to beta interferon
17. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence
18. Beta interferon is produced by Chlamydia trachomatis-infected fibroblast-like synoviocytes and inhibits gamma interferon-induced HLA-DR expression
19. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements
20. Possible involvement of the transcription factor ISGF3γ in virus-induced expression of the IFN-β gene
21. Investigation of IFN type-I receptor and IFN regulatory factor expression relating to induction of 2′,5′-oligoadenylate synthetase in cells persistently infected with the mumps virus
22. Evidence for IRF-1-dependent gene expression deficiency in interferon unresponsive HepG2 cells
23. Induction of interferon synthesis and activation of interferon-stimulated genes by liposomal transfection reagents
24. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells
25. Interaction of Chlamydia pneumoniae and human alveolar macrophages: Infection and inflammatory response
26. In vitro infection of smooth muscle cells by Chlamydia pneumoniae
27. The function of type I interferons in antimicrobial immunity
28. Recombinant interferon-β blocks proliferation but enhances interleukin-10 secretion by activated human T-cells
29. Type I IFNs inhibit human dendritic cell IL-12 production and TH1 development
30. Interferon-beta prevents antigen-induced bronchial inflammation and airway hyperreactivity in mice
31. Suppression of late asthmatic response by low-dose oral administration of interferon-β in the guinea pig model of asthma
32. Differential effects of IFN-β1b on the proliferation of human vascular smooth muscle cells and endothelial cells
33. Inhibition of vascular smooth muscle cell proliferation and intimal hyperplasia by gene transfer of β-interferon
34. Expression of interferon regulatory factors and indoleamine 2,3-dioxygenase in Chlamydia trachomatis-infected synovial fibroblasts
35. Regulation of IFN-α/β genes: Evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN-α/β
36. NFκB activation is required for interferon regulatory factor-1-mediated interferon β induction
37. Chlamydia pneumoniae infection of vascular smooth muscle cells and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression
38. Chlamydia pneumoniae activates nuclear factor κB and activator protein 1 in human vascular smooth muscle cells and induces cellular proliferation
39. Importance of the two interferon-stimulated response element (ISRE) sequences in the regulation of the human indoleamine 2,3-dioxygenase gene
40. Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2,3-dioxygenase activity
41. Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-γ: Role of tryptophan catabolism
42. The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations